Literature DB >> 32248766

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19.

Nisha Muralidharan1, R Sakthivel1, D Velmurugan2, M Michael Gromiha1.   

Abstract

Entities:  

Year:  2020        PMID： 32248766     DOI： 10.1080/07391102.2020.1752802

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN： 0739-1102


× No keyword cloud information.
  78 in total

Review 1.  Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors:  Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

2.  In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19.

Authors:  Rupesh V Chikhale; Saurabh K Sinha; Rajesh B Patil; Satyendra K Prasad; Anshul Shakya; Nilambari Gurav; Rupali Prasad; Suhas R Dhaswadikar; Manish Wanjari; Shailendra S Gurav
Journal:  J Biomol Struct Dyn       Date:  2020-06-24

Review 3.  Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19.

Authors:  Khadga Raj; Karamjeet Kaur; G D Gupta; Shamsher Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-07       Impact factor: 3.000

Review 4.  Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19.

Authors:  Elda M Melchor-Martínez; Nora E Torres Castillo; Rodrigo Macias-Garbett; Sofia Liliana Lucero-Saucedo; Roberto Parra-Saldívar; Juan Eduardo Sosa-Hernández
Journal:  Front Bioeng Biotechnol       Date:  2021-05-14

5.  Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies.

Authors:  Puneet Rawat; Divya Sharma; Ambuj Srivastava; Vani Janakiraman; M Michael Gromiha
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

6.  Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategy.

Authors:  Muthu Kumar T; Rohini K; Nivya James; Shanthi V; Ramanathan K
Journal:  Biotechnol Appl Biochem       Date:  2021-04-14       Impact factor: 2.724

Review 7.  COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.

Authors:  Xueqing Wang; Yuanfang Guan
Journal:  Med Res Rev       Date:  2020-08-30       Impact factor: 12.944

8.  Functional binding dynamics relevant to the evolution of zoonotic spillovers in endemic and emergent Betacoronavirus strains.

Authors:  Patrick Rynkiewicz; Miranda L Lynch; Feng Cui; André O Hudson; Gregory A Babbitt
Journal:  J Biomol Struct Dyn       Date:  2021-07-21

Review 9.  Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review.

Authors:  Humna Sajjad; Mohsin Majeed; Saiqa Imtiaz; Mariyam Siddiqah; Anila Sajjad; Misbahud Din; Muhammad Ali
Journal:  Biologia (Bratisl)       Date:  2021-06-02       Impact factor: 1.653

10.  The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study.

Authors:  Aweke Mulu; Mulugeta Gajaa; Haregewoin Bezu Woldekidan; Jerusalem Fekadu W/Mariam
Journal:  PeerJ       Date:  2021-07-19       Impact factor: 2.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.